Dr. Gerald Hsu is a board-certified medical oncologist based in San Francisco, California. He did his medical school at Duke University School of Medicine and later on completed his residency in internal medicine at the Brigham and Women’s Hospital. He also did a fellowship in hematology/oncology at the UCSF. Dr. Hsu has been practicing for nearly 20 years and is currently affiliated with the Brigham and Women’s Hospital. He has also contributed to three research publications.
Brigham and Women\'s Hospital
American Board of Internal Medicine - Oncology
Circulating proteolytic signatures of chemotherapy-induced cell death in humans discovered by N-terminal labeling.
Wiita, A. P.,Hsu, G. W.,Lu, C. M.,Esensten, J. H.,Wells, J. A.; Proc. Natl. Acad. Sci. U.S.A.. 2014 May 14.See more >>
Ibrutinib rash in a patient with 17p del chronic lymphocytic leukemia.
Mannis, G.,Wu, D.,Dea, T.,Mauro, T.,Hsu, G.; Am. J. Hematol.. 2014 Jun 04.See more >>
Quantitative profiling of caspase-cleaved substrates reveals different drug-induced and cell-type patterns in apoptosis.
Shimbo, K., Hsu, G. W., Nguyen, H., Mahrus, S., Trinidad, J. C., Burlingame, A. L., Wells, J. A.; Proc Natl Acad Sci U S A. 2012 Jul 31.See more >>